Intravitreally Injected HCmel12 Melanoma Cells Serve as a Mouse Model of Tumor Biology of Intraocular Melanoma

References

• Kujala E, Makitie T, Kivela T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 2003;44:4651–4659
   PubMed Web of Science ®Google Scholar
• Singh AD, Shields CL, Shields JA. Prognostic factors in uveal melanoma. Melanoma Res 2001;11:255–263
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646–674
   PubMed Web of Science ®Google Scholar
• Foss AJ, Alexander RA, Jefferies LW, Hungerford JL, Harris AL, Lightman S. Microvessel count predicts survival in uveal melanoma. Cancer Res 1996;56:2900–2903
   PubMed Web of Science ®Google Scholar
• Makitie T, Summanen P, Tarkkanen A, Kivela T. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci 1999;40:2471–2480
   PubMed Web of Science ®Google Scholar
• Ly LV, Odish OF, Wolff-Rouendaal D, Missotten GS, Luyten GP, Jager MJ. Intravascular presence of tumor cells as prognostic parameter in uveal melanoma: a 35-year survey. Invest Ophthalmol Vis Sci 2010;51:658–665
   PubMed Web of Science ®Google Scholar
• Folberg R, Mehaffey M, Gardner LM, Meyer M, Rummelt V, Pe'er J. The microcirculation of choroidal and ciliary body melanomas. Eye (Lond) 1997;11:227–238
   PubMed Web of Science ®Google Scholar
• Seftor RE, Hess AR, Seftor EA, Kirschmann DA, Hardy KM, Margaryan NV, et al. Tumor cell vasculogenic mimicry: from controversy to therapeutic promise. Am J Pathol 2012;181:1115–1125
   PubMed Web of Science ®Google Scholar
• Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer 2003;3:411–421
   PubMed Web of Science ®Google Scholar
• Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012;122:787–795
   PubMed Web of Science ®Google Scholar
• Bronkhorst IH, Jager MJ. Uveal melanoma: the inflammatory microenvironment. J Innate Immun 2012;4:454–462
   PubMed Web of Science ®Google Scholar
• Toivonen P, Makitie T, Kujala E, Kivela T. Microcirculation and tumor-infiltrating macrophages in choroidal and ciliary body melanoma and corresponding metastases. Invest Ophthalmol Vis Sci 2004;45:1–6
   PubMed Web of Science ®Google Scholar
• Nathanson SD. Insights into the mechanisms of lymph node metastasis. Cancer 2003;98:413–423
   PubMed Web of Science ®Google Scholar
• Mendoza M, Khanna C. Revisiting the seed and soil in cancer metastasis. Int J Biochem Cell Biol 2009;41:1452–1462
   PubMed Web of Science ®Google Scholar
• Bakalian S, Marshall JC, Logan P, Faingold D, Maloney S, Di Cesare S, et al. Molecular pathways mediating liver metastasis in patients with uveal melanoma. Clin Cancer Res 2008;14:951–956
   PubMed Web of Science ®Google Scholar
• Sisley K, Rennie IG, Cottam DW, Potter AM, Potter CW, Rees RC. Cytogenetic findings in six posterior uveal melanomas: involvement of chromosomes 3, 6, and 8. Genes Chromosomes Cancer 1990;2:205–209
   PubMed Web of Science ®Google Scholar
• Onken MD, Worley LA, Ehlers JP, Harbour JW. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 2004;64:7205–7209
   PubMed Web of Science ®Google Scholar
• Ehlers JP, Worley L, Onken MD, Harbour JW. Integrative genomic analysis of aneuploidy in uveal melanoma. Clin Cancer Res 2008;14:115–122
   PubMed Web of Science ®Google Scholar
• Mehnert JM, Kluger HM. Driver mutations in melanoma: lessons learned from bench-to-bedside studies. Curr Oncol Rep 2012;14:449–457
   PubMed Web of Science ®Google Scholar
• Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A, Littman DR. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 2000;20:4106–4114
   PubMed Web of Science ®Google Scholar
• Diaz CE, Rusciano D, Dithmar S, Grossniklaus HE. B16LS9 melanoma cells spread to the liver from the murine ocular posterior compartment (PC). Curr Eye Res 1999;18:125–129
   PubMed Web of Science ®Google Scholar
• Landsberg J, Gaffal E, Cron M, Kohlmeyer J, Renn M, Tuting T. Autochthonous primary and metastatic melanomas in Hgf-Cdk4 R24C mice evade T-cell-mediated immune surveillance. Pigment Cell Melanoma Res 2010;23:649–660
   PubMed Web of Science ®Google Scholar
• Dithmar S, Albert DM, Grossniklaus HE. Animal models of uveal melanoma. Melanoma Res 2000;10:195–211
   PubMed Web of Science ®Google Scholar
• Syed NA, Windle JJ, Darjatmoko SR, Lokken JM, Steeves RA, Chappell R, et al. Transgenic mice with pigmented intraocular tumors: tissue of origin and treatment. Invest Ophthalmol Vis Sci 1998;39:2800–2805
   PubMed Web of Science ®Google Scholar
• Albert DM, Kumar A, Strugnell SA, Darjatmoko SR, Lokken JM, Lindstrom MJ, et al. Effectiveness of 1alpha-hydroxyvitamin D2 in inhibiting tumor growth in a murine transgenic pigmented ocular tumor model. Arch Ophthalmol 2004;122:1365–1369
   PubMed Web of Science ®Google Scholar
• Kramer TR, Powell MB, Wilson MM, Salvatore J, Grossniklaus HE. Pigmented uveal tumours in a transgenic mouse model. Br J Ophthalmol 1998;82:953–960
   PubMed Web of Science ®Google Scholar
• Latendresse JR, Muskhelishvili L, Warbritton A, Tolleson WH. Two cases of uveal amelanotic melanoma in transgenic Tyr-HRAS+ Ink4a/Arf heterozygous mice. Toxicol Pathol 2007;35:827–832
   PubMedGoogle Scholar
• Tolleson WH, Doss JC, Latendresse J, Warbritton AR, Melchior WB Jr, Chin L, et al. Spontaneous uveal amelanotic melanoma in transgenic Tyr-RAS+ Ink4a/Arf-/- mice. Arch Ophthalmol 2005;123:1088–1094
   PubMed Web of Science ®Google Scholar
• Mueller AJ, Maniotis AJ, Freeman WR, Bartsch DU, Schaller UC, Bergeron-Lynn G, et al. An orthotopic model for human uveal melanoma in SCID mice. Microvasc Res 2002;64:207–213
   PubMed Web of Science ®Google Scholar
• Lattier JM, Yang H, Crawford S, Grossniklaus HE. Host pigment epithelium-derived factor (PEDF) prevents progression of liver metastasis in a mouse model of uveal melanoma. Clin Exp Metastasis 2013;30:969–976
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang S, Li X, Sun B, Zhao X, Zhang D, Zhao S. A pilot study of vasculogenic mimicry immunohistochemical expression in intraocular melanoma model. Oncol Rep 2009;21:989–994
   PubMed Web of Science ®Google Scholar
• Grossniklaus HE. Tumor vascularity and hematogenous metastasis in experimental murine intraocular melanoma. Trans Am Ophthalmol Soc 1998;96:721–752
   PubMedGoogle Scholar
• Onken MD, Lin AY, Worley LA, Folberg R, Harbour JW. Association between microarray gene expression signature and extravascular matrix patterns in primary uveal melanomas. Am J Ophthalmol 2005;140:748–749
   PubMed Web of Science ®Google Scholar
• Onken MD, Worley LA, Char DH, Augsburger JJ, Correa ZM, Nudleman E, et al. Collaborative ocular oncology group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology 2012;119:1596–1603
   PubMed Web of Science ®Google Scholar
• Hurst EA, Harbour JW, Cornelius LA. Ocular melanoma: a review and the relationship to cutaneous melanoma. Arch Dermatol 2003;139:1067–1073
   PubMed Web of Science ®Google Scholar